About: Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.46 (-1.60%)
ACET NASDAQ Adicet Bio Inc
Adicet Bio Inc share price
ACET price activity
Last Price
$2.140
Change (24hr)
-0.32 USD (13.01%)
Volume
760.29K
Volume (4w avg)
-
Open
$2.43
Day Range
$2.12 - $2.53
Previous Close
$2.46
Last Trade
20 Nov, 9:00 pm GMT+0
Delayed
20 Nov, 9:00 pm GMT+0
ACET price performance
Delayed
20 Nov, 9:00 pm GMT+0
ACET details
ACET Market Signals